SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle ($ORCL) is trending due to a mixed earnings report and concerns about increasing debt related to AI infrastructure investments, leading to a sharp decline in stock value. The community is debating whether this drop is an overreaction, a buying opportunity, or a sign of deeper issues with Oracle's AI strategy and financial management. Analyst ratings are being adjusted, and the impact on the broader AI sector and Oracle's long-term prospects is under scrutiny.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending due to its potential for a short squeeze, fueled by a low float and high short interest, as well as its upcoming presentation at an emerging growth conference. Community members are actively discussing the company's shift towards AI and digital infrastructure, viewing it as undervalued compared to its peers, and anticipating potential catalysts from the conference. The stock's volatile price action and history of explosive moves are also contributing to the heightened interest.

AXIL Brands, Inc. engages in the manufacture, market, sale and distribution of hearing and audio enhancement, and protection products. It operates through the Hearing Enhancement and Protection, and Hair Care and Skin Care segments. The Hearing Enhancement and Protection segment includes ear buds, earmuffs, ear plugs, outdoor speakers, and ear care items. The Hair Care and Skin Care segment focuses on expanding its business-to-business salon sales through its network of domestic and international distributors. The company was founded on May 21, 2015 and is headquartered in Beverly Hills, CA.

AXIL Brands Inc.

AXIL is trending due to news of a national retail distribution agreement with Walmart, set to launch in February 2026. Community chatter highlights potential for significant gains and the stock's low float, while some caution against potential dilution risks and the company's small size.

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.

Rezolute Inc

RZLT is trending due to Phase 3 study results for its congenital hyperinsulinism treatment; while the study didn't meet its primary endpoint, the community is debating the comparability to existing options and potential for limited label approval. Trading was halted following the news, and shareholders anticipate a rough day, with some speculating about a possible acquisition deal despite the disappointing results. Discussions also involve the company's cash runway and the limited market size for its lead drug candidate.

iRobot Corp. is a robot company, which engages in designing and building robots. The firm's products include robot vacuums and maps, and pool cleaners. It operates through Domestic and International geographical segments. The company was founded by Rodney Allen Brooks, Colin M. Angle, and Helen Greiner in August 1990 and is headquartered in Bedford, MA.

Irobot Corp

iRobot Corp

IRBT is trending as traders discuss a potential short squeeze, citing very high short interest and recent price movement. Community members are pointing to the difficulty in borrowing shares and high borrowing fees as further indicators of a possible squeeze. Some are expressing caution, noting the company's fundamentals and potential for a bull trap.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending as investors debate its current valuation and future prospects, especially after recent CFO commentary sparked concerns about growth in branded checkout volume. The community is split, with some viewing it as an undervalued opportunity due to strong fundamentals and buyback programs, while others express frustration over management's communication and the stock's stagnant performance relative to the broader market. Broader discussions involve the fintech sector, with some suggesting a potential Microsoft-like turnaround while others fear continued underperformance.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending as retail traders debate its S&P 500 inclusion and what it means for the stock's future, as well as high short interest. Community members are actively discussing whether the stock is overvalued, with some calling it a high-beta squeeze risk, while others point to potential manipulation. The stock's impressive run has sparked debates about its fundamentals versus market mechanics.

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.

Corbus Pharmaceuticals Holdings Inc

Corbus Pharmaceuticals is trending due to Phase 1a results of CRB-913, an obesity treatment, showing a favorable safety profile and some evidence of weight loss. The community is actively discussing the potential of CRB-913 as a promising oral obesity asset and a possible acquisition target, while also weighing the implications of these results given the history of the stock.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending amid discussions about a potential buyout and the company's recent progress in its DM1 clinical study. Community members are debating the stock's valuation, upcoming milestones, and the potential impact of competitor data, while also analyzing recent analyst ratings and institutional ownership.

Beasley Broadcast Group, Inc. is multi-platform media company, which engages in the operation of radio stations in the United States. The firm offers marketing solutions across event platforms. It operates through the following business segments: Audio, Digital, and Other. The company was founded by George G. Beasley in 1961 and is headquartered in Naples, FL.

Beasley Broadcast Group Inc - Ordinary Shares - Class A

BBGI is trending due to a massive intraday price surge, fueled by its low float and significant volume, leading to discussions about potential short squeezes and comparisons to other recent high-flying stocks. The community is actively debating whether the run has ended or if there is potential for further gains, with some cautioning about bag holding and others anticipating after-hours momentum. Overall, traders are focused on the stock's volatile price action and potential for quick profits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The insecticide and herbicide maker projected 2025 revenue of $3.92 billion to $4.02 billion in October, down from its previous forecast of $4.08 billion to $4.28 billion.</li><li>The research firm stated that FMC faces a "tough" near-to-medium-term outlook, with management citing only limited growth potential over the next three years, the analyst noted.</li><li>FMC previously warned that it would continue to grapple with tepid prices amid a high influx of generic products.</li></ul>FMC stock slipped over 1% in premarket trading on Tuesday, after Barclays turned less optimistic about the company’s near-term results.As per TheFly, Barclays analyst Benjamin Theurer downgraded FMC to ‘Underweight’ from ‘Equal Weight’ and lowered the price target to $13 from $16. The new price target was marginally below FMC stock’s Monday closing price of $13.10. FMC stock has fallen by over 73% this year.<h2 class="st-heading-2">What Did The Analyst Say?</h2>The Barclays analyst expects the agriculture markets to see mixed results in 2026. The research firm stated that FMC faces a "tough" near-to-medium-term outlook, with management citing only limited growth potential over the next three years.The insecticide and herbicide maker projected 2025 revenue of $3.92 billion to $4.02 billion in October, down from its previous forecast of $4.08 billion to $4.28 billion. FMC also cut its earnings-per-share estimates to $2.92 to $3.14, down from $3.26 to $3.70 earlier.FMC stated pricing is expected to have a mid-to-high single-digit percentage-point impact on its full-year earnings, as it continues to grapple with a high influx of generic products, which are hampering sales of the company’s proprietary products. Its Latin American sales fell 8% year over year in the third quarter.The company added that low customer liquidity caused credit constraints in Brazil and Argentina, further inhibiting growth. Prices of key crops such as soybeans and corn have remained under pressure for much of the year, prompting farmers to cut spending on insecticides and fungicides.<h2 class="st-heading-2">Debt Relief</h2>On Monday, FMC amended its credit agreement to ease financial covenants and extend its covenant relief period to 2028. The amendment also limits subsidiary indebtedness to a maximum aggregate outstanding principal amount of $350 million, subject to certain exceptions. It limits increases to the company’s regular quarterly dividend above $0.08 per share.<h2 class="st-heading-2">What Are Stocktwits Users Thinking?</h2>Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/FMC">FMC</a> was in ‘neutral’ territory at the time of writing, compared to ‘bearish’ a day earlier.<figure class="image"><img style="aspect-ratio:718/89;" src="https://news.stocktwits-cdn.com/FMC_Dec_9_JPG_f7e1cf1f20.webp" alt="FMC’s Sentiment Meter and Message Volume as of 08:17 a.m. ET on Dec. 9, 2025 | Source: Stocktwits" width="718" height="89"><figcaption>FMC’s Sentiment Meter and Message Volume as of 08:17 a.m. ET on Dec. 9, 2025 | Source: Stocktwits</figcaption></figure>One user on Stocktwits said he expects the share price to cross $50 by 2028 as new products get introduced, after the banks gave the company more time to recover.<a href="https://stocktwits.com/ssdsddssd2/message/638580327">https://stocktwits.com/ssdsddssd2/message/638580327</a>Also See: <a href="https://stocktwits.com/news-articles/markets/equity/cemtrex-stock-in-spotlight-after-a-year-of-turbulence/cLIruf8REZB">Cemtrex Stock In Spotlight After A Year Of Turbulence — A Look At Some Of The Strategic Moves This Year</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the FMC Corporation logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

This Pesticide Maker's Stock Has Slid Over 73% In 2025 — Barclays Sees Further Pain

Barclays analyst Benjamin Theurer downgraded FMC to ‘Underweight’ from ‘Equal Weight’ and lowered the price target to $13 from $16.

Equity

ADM (ADM) Up 6.2% Since Last Earnings Report: Can It Continue?

ADM (ADM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields

FMC Corporation (NYSE:FMC) Receives Consensus Recommendation of "Hold" from Analysts

Shares of FMC Corporation (NYSE:FMC - Get Free Report) have been given a consensus rating of "Hold" by the sixteen analysts that are presently covering the company, MarketBeat reports. Two investment...

FMC (FMC) Down 10.2% Since Last Earnings Report: Can It Rebound?

FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Rep. Lisa C. McClain Purchases Shares of FMC Corporation (NYSE:FMC)

Representative Lisa C. McClain (R-Michigan) recently bought shares of FMC Corporation (NYSE:FMC). In a filing disclosed on November 21st, the Representative disclosed that they had bought between...

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

FMC
FMC Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FMC News

FMCFMC Corp.